Cannabics Pharmaceuticals Inc. announced that Dr. Ilya Reznik (MD), a renowned Neuropsychiatrist, has joined the company as Head of Psychedelic Inspired Medicine. The nomination of Dr. Reznik is part of the company's strategy to develop new psychedelic inspired medicines and therapies to address several mental health related conditions. The announcement follows the company's recent launching of a Psilocybin and Psilocin Research Program taking place under license by Israeli Ministry of Health. Dr. Ilya Reznik is a Board-certified specialist in Adult Forensic & Clinical NeuroPsychiatry at MaReNa Diagnostic and Consulting Center, Israel. Dr. Ilya Reznik has superior educational and professional record and documented contributions to the field of neuropsychiatric research, such as publications and other innovative activities. In 2019 Dr. Ilya Reznik was appointed as IACM Secretary for Partnership & Networking and promotes Educational and International activity within IACM.